Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Bioequivalence study of amodiaquine hydrochloride tablets
- At: 2007 FIP Congress in Beijing (China)
- Type: Poster
- By: ZHONG, Dafang (Shanghai Institute of Materia Medica, Shanghai, China)
- Co-author(s): Chen, Xiaoyan (Shanghai Institute of Materia Medica, SHANGHAI, China)
Dai, Xiaojian (Shanghai Institute of Materia Medica, SHANGHAI, China)
Gao, Zhiwei (Shanghai Institute of Materia Medica, SHANGHAI, China) - Abstract:
OBJECTIVE To determine the bioequivalence of Amodiaquine Hydrochloride Tablets (test product) of Guilin Pharmaceutical Co., Ltd, China as compared to FlavoquineÂ[RSYMBOL] Tablets (reference product) of Laboratoire Aventis, France. METHODS The study was conducted as an open-label randomized, two-treatment, two-period, cross-over single-dose study..
The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 October 2019